In the last trading session, 8.25 million Merck & Co Inc (NYSE:MRK) shares changed hands as the company’s beta touched 0.38. With the company’s per share price at $125.52 changed hands at $0.21 or 0.17% during last session, the market valuation stood at $317.90B. MRK’s last price was a discount, traded about -3.76% off its 52-week high of $130.24. The share price had its 52-week low at $99.14, which suggests the last value was 21.02% up since then. When we look at Merck & Co Inc’s average trading volume, we note the 10-day average is 12.72 million shares, with the 3-month average coming to 8.45 million.
Merck & Co Inc (NYSE:MRK) trade information
Instantly MRK was in green as seen at the end of in last trading. With action 2.72%, the performance over the past five days has been green. The jump to weekly highs of 126.08 added 0.17% to the stock’s daily price. The company’s shares are showing year-to-date upside of 15.13%, with the 5-day performance at 2.72% in the green. However, in the 30-day time frame, Merck & Co Inc (NYSE:MRK) is -2.58% down. Looking at the short shares, we see there were 16.6 million shares sold at short interest cover period of 2.3 days.
Merck & Co Inc (MRK) estimates and forecasts
Data shows that the Merck & Co Inc share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot 18.59% over the past 6 months, a 468.21% in annual growth rate that is considerably higher than the industry average of 4.40%. Moreover, analysts have looked to higher expectations by upgrading its fiscal year 2024 revenue estimates. The rating firms predict current quarter revenue for Merck & Co Inc will rise 47.10%, while the growth in revenue is estimated to hit 198.10% for the next quarter. Year-over-year growth is forecast to reach 6.20% up from the last financial year.
Consensus estimates given by 12 financial analysts project the company’s revenue in the current quarter to hit an average of $15.13 billion. 12 analysts are of the opinion that Merck & Co Inc’s revenue for the quarter ending Jun 2024 will be $15.84 billion. The company’s revenue for the corresponding quarters a year ago was $13.78 billion and $15.04 billion respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 9.70%. The estimates for the next quarter sales put growth at 5.30%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -42.70%. The 2024 estimates are for Merck & Co Inc earnings to increase by 468.84%, but the outlook for the next 5-year period is at 67.56% per year.
MRK Dividends
Merck & Co Inc is expected to release its next quarterly earnings report on April 25. The 2.39% annual yield figure for the share gives it an annual dividend of 3.00. It is important to note, however, that the 2.39% dividend yield ratio should serve as a guide only, as you should also take into consideration many other aspects of a company’s operations and fundamentals before making any investment decision.
